HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gut Microbiome among Children with Uncomplicated Severe Acute Malnutrition in a Randomized Controlled Trial of Azithromycin versus Amoxicillin.

Abstract
Antibiotics are routinely used as part of the management of severe acute malnutrition and are known to reduce gut microbial diversity in non-malnourished children. We evaluated gut microbiomes in children participating in a randomized controlled trial (RCT) of azithromycin versus amoxicillin for severe acute malnutrition. Three hundred one children aged 6 to 59 months with uncomplicated severe acute malnutrition (mid-upper arm circumference < 11.5 cm and/or weight-for-height Z-score < -3 without clinical complications) were enrolled in a 1:1 RCT of single-dose azithromycin versus a 7-day course of amoxicillin (standard of care). Of these, 109 children were randomly selected for microbiome evaluation at baseline and 8 weeks. Rectal swabs were processed with metagenomic DNA sequencing. We compared alpha diversity (inverse Simpson's index) at 8 weeks and evaluated relative abundance of microbial taxa using DESeq2. Of 109 children enrolled in the microbiome study, 95 were followed at 8 weeks. We found no evidence of a difference in alpha diversity between the azithromycin and amoxicillin groups at 8 weeks controlling for baseline diversity (mean difference -0.6, 95% CI -1.8 to 0.6, P = 0.30). Gut microbiomes did not diversify during the study. Differentially abundant genera at the P < 0.01 level included Salmonella spp. and Shigella spp., both of which were overabundant in the azithromycin compared with amoxicillin groups. We found no evidence to support an overall difference in gut microbiome diversity between azithromycin and amoxicillin among children with uncomplicated severe acute malnutrition, but potentially pathogenic bacteria that can cause invasive diarrhea were more common in the azithromycin group. Trial Registration: ClinicalTrials.gov NCT03568643.
AuthorsCatherine E Oldenburg, Armin Hinterwirth, Clarisse Dah, Ourohiré Millogo, Boubacar Coulibaly, Moussa Ouedraogo, Ali Sié, Cindi Chen, Lina Zhong, Kevin Ruder, Elodie Lebas, Fanice Nyatigo, Benjamin F Arnold, Kieran S O'Brien, Thuy Doan
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 108 Issue 1 Pg. 206-211 (01 11 2023) ISSN: 1476-1645 [Electronic] United States
PMID36509053 (Publication Type: Randomized Controlled Trial, Journal Article)
Chemical References
  • Azithromycin
  • Amoxicillin
  • Anti-Bacterial Agents
Topics
  • Child
  • Humans
  • Infant
  • Azithromycin (therapeutic use)
  • Amoxicillin (therapeutic use)
  • Gastrointestinal Microbiome
  • Anti-Bacterial Agents (therapeutic use)
  • Severe Acute Malnutrition
  • Malnutrition

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: